Hear hear! Ear gene therapy player Akouos draws $105M in fresh capital

Thriving on the momentum of biotechnology companies working on therapies to address hearing loss, Boston-based Akouos has scored $105 million in an oversubscribed Series B financing, less than two years after an NEA, 5AM Ventures-backed $50 million haul.